Eli Lilly and Co

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: 43K

Market Cap: $859.4B

Website

Introduction: Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Clinical Trials

A Study of LY3143753 and LY3185643 in Healthy Participants

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: LY3143753 (Part A)
Drug: LY3185643 (Part B)
Drug: Placebo (Part A and Part B)
Drug: rGlucagon (Part B)

First Posted Date: 2015-01-19

Last Posted Date: 2019-03-13

Lead Sponsor: Eli Lilly and Company

Target Recruit Count: 68

Registration Number: NCT02342314

Locations: 🇬🇧
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Leeds, United Kingdom

A Study to Measure Baricitinib (LY3009104) Absorption in Healthy Participants

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: Baricitinib
Drug: [^13C4D3^15N]-baricitinib

First Posted Date: 2015-01-16

Last Posted Date: 2017-06-01

Lead Sponsor: Eli Lilly and Company

Target Recruit Count: 8

Registration Number: NCT02340104

Locations: 🇬🇧
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY, Leeds, Yorkshire, United Kingdom

A Study of 2 Different Formulations of Blosozumab (LY2541546) in Post Menopausal Women

Phase 1

Terminated

Conditions: Osteoporosis, Postmenopausal

Interventions: Other: Placebo
Biological: Blosozumab

First Posted Date: 2015-01-13

Last Posted Date: 2019-01-22

Lead Sponsor: Eli Lilly and Company

Target Recruit Count: 28

Registration Number: NCT02337387

Locations: 🇺🇸
Covance, Dallas, Texas, United States
🇺🇸
Covance Clinical Research Inc, Evansville, Indiana, United States

An Extension Study of Duloxetine in Osteoarthritis and Knee Pain (Extension of F1J-JE-HMGX, NCT02248480)

Phase 3

Completed

Conditions: Osteoarthritis of the Knee

Interventions: Drug: Duloxetine

First Posted Date: 2015-01-09

Last Posted Date: 2019-09-18

Lead Sponsor: Eli Lilly and Company

Target Recruit Count: 93

Registration Number: NCT02335346

Locations: 🇯🇵
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Kobe, Japan

A Study of LY2835219 in Healthy Participants

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: LY2835219
Drug: ¹³C₈-LY2835219

First Posted Date: 2014-12-30

Last Posted Date: 2018-08-06

Lead Sponsor: Eli Lilly and Company

Target Recruit Count: 11

Registration Number: NCT02327143

Locations: 🇬🇧
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Leeds, United Kingdom

A Study of Olaratumab and Doxorubicin in Participants With Advanced Soft Tissue Sarcoma

Phase 1

Completed

Conditions: Sarcoma, Soft Tissue

Interventions: Drug: Olaratumab
Drug: Doxorubicin

First Posted Date: 2014-12-25

Last Posted Date: 2019-11-21

Lead Sponsor: Eli Lilly and Company

Target Recruit Count: 49

Registration Number: NCT02326025

Locations: 🇺🇸
UCLA Medical Center, Los Angeles, California, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
Washington University Medical Center, Saint Louis, Missouri, United States

and more 3 locations

A Study of LY3202626 in Healthy Participants and Participants With Alzheimer's Disease

Phase 1

Completed

Conditions: Alzheimer Disease
Healthy Volunteers

Interventions: Drug: LY3202626
Drug: Placebo (Part A, B, C)
Drug: Itraconazole

First Posted Date: 2014-12-23

Last Posted Date: 2021-04-19

Lead Sponsor: Eli Lilly and Company

Target Recruit Count: 94

Registration Number: NCT02323334

Locations: 🇺🇸
California Clinical Trials Medical Group, Glendale, California, United States

A Study of LY900014 Formulations in Healthy Participants

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Biological: Insulin Lispro
Biological: LY900014

First Posted Date: 2014-12-16

Last Posted Date: 2020-05-13

Lead Sponsor: Eli Lilly and Company

Target Recruit Count: 29

Registration Number: NCT02317575

Locations: 🇸🇬
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore, Singapore

A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer

Phase 3

Completed

Conditions: Gastroesophageal Junction Adenocarcinoma
Metastatic Gastric Adenocarcinoma

Interventions: Drug: Ramucirumab
Drug: Capecitabine
Drug: Placebo
Drug: Cisplatin
Drug: Fluorouracil

First Posted Date: 2014-12-10

Last Posted Date: 2021-08-26

Lead Sponsor: Eli Lilly and Company

Target Recruit Count: 645

Registration Number: NCT02314117

Locations: 🇺🇸
UT Southwestern Med Ctr, Dallas, Texas, United States
🇺🇸
Comprehensive Blood and Cancer Center, Bakersfield, California, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

and more 28 locations

A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain

Phase 2

Completed

Conditions: Breast Cancer
Melanoma
Brain Metastases
Non-small Cell Lung Cancer

Interventions: Drug: Abemaciclib

First Posted Date: 2014-12-04

Last Posted Date: 2020-12-19

Lead Sponsor: Eli Lilly and Company

Target Recruit Count: 162

Registration Number: NCT02308020

Locations: 🇺🇸
University of California - San Diego, La Jolla, California, United States
🇺🇸
John Wayne Cancer Institute, Santa Monica, California, United States
🇺🇸
Georgetown University Medical Center, Washington, District of Columbia, United States

and more 20 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy